Microbial translocation and T cell activation are modified by direct-acting antiviral therapy in HCV-infected patients.
Barbara LattanziSilvia BaroncelliAdriano De SantisClementina Maria GalluzzoGianluca MenniniZuleika MicheliniMarinella LupoStefano Ginanni CorradiniMassimo RossiLucia PalmisanoManuela MerliPublished in: Alimentary pharmacology & therapeutics (2018)
Surrogate microbial translocation markers and T cell activation are increased in HCV-infected patients with liver fibrosis and decrease during direct-acting antiviral treatment.